tiprankstipranks
Advertisement
Advertisement
Relay Therapeutics price target raised to $21 from $19 at Citizens
PremiumThe FlyRelay Therapeutics price target raised to $21 from $19 at Citizens
11d ago
Relay Therapeutics price target raised to $27 from $21 at Barclays
Premium
The Fly
Relay Therapeutics price target raised to $27 from $21 at Barclays
11d ago
Relay Therapeutics announces $175M common stock offering
Premium
The Fly
Relay Therapeutics announces $175M common stock offering
11d ago
Midday Fly By: Home Depot reports Q1 beat, Blackstone and Google form cloud JV
PremiumThe FlyMidday Fly By: Home Depot reports Q1 beat, Blackstone and Google form cloud JV
11d ago
Relay Therapeutics price target raised to $26 from $23 at Raymond James
Premium
The Fly
Relay Therapeutics price target raised to $26 from $23 at Raymond James
11d ago
TD Cowen sees Relay’s Phase 2 zovegalisib data ‘a best-case scenario’
Premium
The Fly
TD Cowen sees Relay’s Phase 2 zovegalisib data ‘a best-case scenario’
11d ago
Relay Therapeutics’ zovegalisib shows potential efficacy in vascular anomalies
PremiumThe FlyRelay Therapeutics’ zovegalisib shows potential efficacy in vascular anomalies
12d ago
Relay Therapeutics price target raised to $25 from $19 at H.C. Wainwright
Premium
The Fly
Relay Therapeutics price target raised to $25 from $19 at H.C. Wainwright
1M ago
Relay Therapeutics price target raised to $18 from $14 at Oppenheimer
Premium
The Fly
Relay Therapeutics price target raised to $18 from $14 at Oppenheimer
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100